 | Up a level |
Gantenbein, Andreas R; Bonvin, Christophe; Kamm, Christian P; Schankin, Christoph J; Zecca, Chiara; Zieglgänsberger, Dominik; Merki-Feld, Gabriele Susanne; Pohl, Heiko; Rudolph, Nicole; Ryvlin, Philippe; Agosti, Reto; Schäfer, Elisabeth; Meyer, Ina; Kulartz-Schank, Monika; Arzt, Michael E (2024). Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results. Journal of neurology, 271(8), pp. 5402-5410. Springer 10.1007/s00415-024-12470-6
Gantenbein, Andreas R; Agosti, Reto; Kamm, Christian P; Landmann, Gunther; Meier, Niklaus; Merki-Feld, Gabriele Susanne; Petersen, Jens A; Pohl, Heiko; Ryvlin, Philippe; Schankin, Christoph J; Viceic, Dragana; Zecca, Chiara; Schäfer, Elisabeth; Meyer, Ina; Arzt, Michael E (2022). Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. The journal of headache and pain, 23(1), p. 161. BioMed Central 10.1186/s10194-022-01530-9
Gantenbein, Andreas R; Agosti, Reto; Kamm, Christian P; Landmann, Gunther; Meier, Niklaus; Merki-Feld, Gabriele Susanne; Petersen, Jens A; Pohl, Heiko; Ryvlin, Philippe; Schankin, Christoph J; Viceic, Dragana; Zecca, Chiara; Schäfer, Elisabeth; Meyer, Ina; Arzt, Michael E (2022). Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. The journal of headache and pain, 23(1), p. 142. 10.1186/s10194-022-01515-8
Merki-Feld, Gabriele S; Sandor, Peter S; Nappi, Rossella E; Pohl, Heiko; Schankin, Christoph (2022). Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study. Acta neurologica Belgica, 122(2), pp. 401-409. Springer 10.1007/s13760-021-01677-3
Gantenbein, Andreas R; Agosti, Reto; Gobbi, Claudio; Flügel, Dominique; Schankin, Christoph J.; Viceic, Dragana; Zecca, Chiara; Pohl, Heiko (2021). Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study. Cephalalgia, 41(11-12), pp. 1181-1186. Sage Publications 10.1177/03331024211014616
García-Azorín, David; Do, Thien Phu; Gantenbein, Andreas R; Hansen, Jakob Møller; Souza, Marcio Nattan P; Obermann, Mark; Pohl, Heiko; Schankin, Christoph J.; Schytz, Henrik Winther; Sinclair, Alexandra; Schoonman, Guus G; Kristoffersen, Espen Saxhaug (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), p. 108. BioMed Central 10.1186/s10194-021-01324-5
Pohl, Heiko; Andrée, Colette; Biethahn, Silke; Emmenegger, Mark; Flügel, Dominique; Jung, Hans H; Kleinschmidt, Andreas; Palla, Antonella; Sandor, Peter; Schankin, Christoph; Schmidt, Holger; Sturzenegger, Mathias; Gantenbein, Andreas R (2021). [Smarter Medicine in Headache Care - presentation and discussion of 5 recommendations]. Therapeutische Umschau, 78(7), pp. 341-348. Huber 10.1024/0040-5930/a001282
Pohl, Heiko; Do, Thien Phu; García-Azorín, David; Hansen, Jakob Møller; Kristoffersen, Espen Saxhaug; Nelson, Sarah E; Obermann, Mark; Sandor, Peter S; Schankin, Christoph J.; Schytz, Henrik Winther; Sinclair, Alexandra; Schoonman, Guus G; Gantenbein, Andreas R (2021). Green Flags and headache: A concept study using the Delphi method. Headache, 61(2), pp. 300-309. Wiley-Blackwell 10.1111/head.14054
Sandor, Peter S.; Gantenbein, Andreas R.; Pohl, Heiko; Fischer, Urs (2019). CGRP-MoAbs – «game changer» in der Migräneprophylaxe? Swiss Medical Forum, 19(1-2), pp. 24-25. EMH Swiss Medical Publishers 10.4414/smf.2019.03431
